10x Genomics to Report Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024

PLEASANTON, Calif., Jan. 24, 2024 /PRNewswire/ — 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that it will report financial results for the fourth quarter and full year ended December 31, 2023 after market close on Thursday, February 15,…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks